1986
DOI: 10.1111/j.1365-2125.1986.tb02870.x
|View full text |Cite
|
Sign up to set email alerts
|

Verapamil in angina pectoris.

Abstract: 1 New knowledge of the pathophysiology of coronary disease has helped determine the therapy for angina pectoris. Calcium antagonists have the advantage of being direct coronary vasodilators as well as decreasing overall demand by systemic vasodilatation. 2 Verapamil has the same anti-anginal effect during exercise as 0-adrenoceptor blockers but has the advantage of increasing rather than decreasing the cardiac output and so fatigue both at rest and exercise commonly seen with P-adrenoceptor blockers is not fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1994
1994
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 4 publications
(4 reference statements)
0
1
0
Order By: Relevance
“… 41 Verapamil (VER), as a calcium channel blocker, can be used for the prevention and relief of angina pectoris. 42 , 43 Also, it has been extensively studied as a positive control drug in myocardial ischemia experiments 44 , 45 and has shown significant anti-ischemic effects. 46 , 47 Therefore, VER was used as a positive control drug in this research.…”
Section: Discussionmentioning
confidence: 99%
“… 41 Verapamil (VER), as a calcium channel blocker, can be used for the prevention and relief of angina pectoris. 42 , 43 Also, it has been extensively studied as a positive control drug in myocardial ischemia experiments 44 , 45 and has shown significant anti-ischemic effects. 46 , 47 Therefore, VER was used as a positive control drug in this research.…”
Section: Discussionmentioning
confidence: 99%